跳至主要内容
临床试验/EUCTR2012-004892-37-NL
EUCTR2012-004892-37-NL进行中(未招募)1 期

Acetylcysteine in patients with Sickle Cell Disease: Reducing the incidence of daily life pain in patients with sickle cell disease - NAC Trial

Academic Medical Center0 个研究点目标入组 140 人开始时间: 2013年3月21日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Age 12 years or older
  • -Sickle cell disease, either homozygous sickle cell disease (HbSS), HbSC sickle cell
  • disease, HbSß0 or HbSß+ thalassemia.
  • Genotype needs to be confirmed by high performance liquid chromatography.
  • -History of at least 1.0 painful crisis per year in the past 3 years.
  • A crisis will be defined here as a patient defined, painful, sickle cell related episode of at least 24 hours where a subject experienced significant impediments in his/her daily activities, and pain medication had to be taken. A visit to a medical facility is not obligatory in this definition.
  • -Written informed consent from patient/parent/guardian is given.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 30
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 90
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 20

排除标准

  • -Chronic blood transfusion or transfusion in the preceding 3 months
  • -Painful crisis in the last 4 weeks (with respect to the moment of inclusion).
  • A crisis will be defined as above; a patient defined, painful, sickle cell related episode of at least 24 hours where the subject experienced significant impediments in his/her daily activities, and pain medication had to be taken. A visit to a medical facility is not obligatory in this definition.
  • -Pregnancy, breast feeding or the desire to get pregnant in the following 7 months
  • -Known active gastric/duodenal ulcers
  • -Hydroxycarbamide (HC) treatment with unstable dose in the last 3 months or started on
  • HC shorter then 6 months prior to study.
  • -Known poor compliance in earlier trials regarding the completion of pain diaries.
  • -Insufficient compliance in run-in period.
  • Participants that do not show up for their follow-up visit without prior notice, that not bring
  • their diary or with less than 80% of the days in the pain diary filled in, will be excluded from participation in this trial and will not be randomized.

研究者

发起方
Academic Medical Center

相似试验

Acetylcysteine in patients with Sickle Cell Disease:... | 临床试验